A detailed history of J. W. Coons Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, J. W. Coons Advisors, LLC holds 18,820 shares of BMY stock, worth $1.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,820
Previous 18,820 -0.0%
Holding current value
$1.1 Million
Previous $781,000 24.58%
% of portfolio
0.18%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$40.25 - $52.99 $100,625 - $132,475
-2,500 Reduced 11.73%
18,820 $781,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $48,480 - $57,850
-1,000 Reduced 4.48%
21,320 $1.09 Million
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $54,706 - $61,169
-945 Reduced 4.06%
22,320 $1.3 Million
Q4 2022

Feb 07, 2023

BUY
$68.48 - $81.09 $253,376 - $300,033
3,700 Added 18.91%
23,265 $1.67 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $57 - $34,193
445 Added 2.33%
19,565 $1.39 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $111,471 - $122,769
-1,535 Reduced 7.43%
19,120 $1.48 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $146,322 - $175,453
-2,380 Reduced 10.33%
20,655 $1.51 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $12,603 - $14,692
-235 Reduced 1.01%
23,035 $1.43 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $5,976 - $7,000
-101 Reduced 0.43%
23,270 $1.38 Million
Q2 2021

Jul 22, 2021

BUY
$61.91 - $67.42 $37,146 - $40,452
600 Added 2.63%
23,371 $1.56 Million
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $15,428 - $17,352
260 Added 1.15%
22,771 $1.44 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $26,560 - $30,097
460 Added 2.09%
22,511 $1.4 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $159,540 - $176,791
2,778 Added 14.41%
22,051 $1.33 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $894,267 - $1.3 Million
19,273 New
19,273 $1.08 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track J. W. Coons Advisors, LLC Portfolio

Follow J. W. Coons Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. W. Coons Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J. W. Coons Advisors, LLC with notifications on news.